These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2278823)

  • 1. Experimental visceral leishmaniasis: sequential events of granuloma formation at subcutaneous inoculation site.
    Laurenti MD; Sotto MN; Corbett CE; da Matta VL; Duarte MI
    Int J Exp Pathol; 1990 Dec; 71(6):791-7. PubMed ID: 2278823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early histopathology of experimental infection with Leishmania donovani in hamsters.
    Wilson ME; Innes DJ; Sousa AD; Pearson RD
    J Parasitol; 1987 Feb; 73(1):55-63. PubMed ID: 3572666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathology of lymphoid organs in experimental leishmaniasis.
    Corbett CE; Paes RA; Laurenti MD; Andrade Júnior HF; Duarte MI
    Int J Exp Pathol; 1992 Aug; 73(4):417-33. PubMed ID: 1390190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elongation factor-2, a Th1 stimulatory protein of Leishmania donovani, generates strong IFN-γ and IL-12 response in cured Leishmania-infected patients/hamsters and protects hamsters against Leishmania challenge.
    Kushawaha PK; Gupta R; Sundar S; Sahasrabuddhe AA; Dube A
    J Immunol; 2011 Dec; 187(12):6417-27. PubMed ID: 22079980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination with a novel recombinant Leishmania antigen plus MPL provides partial protection against L. donovani challenge in experimental model of visceral leishmaniasis.
    Bhardwaj S; Vasishta RK; Arora SK
    Exp Parasitol; 2009 Jan; 121(1):29-37. PubMed ID: 18983842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization with the DNA-encoding N-terminal domain of proteophosphoglycan of Leishmania donovani generates Th1-type immunoprotective response against experimental visceral leishmaniasis.
    Samant M; Gupta R; Kumari S; Misra P; Khare P; Kushawaha PK; Sahasrabuddhe AA; Dube A
    J Immunol; 2009 Jul; 183(1):470-9. PubMed ID: 19542458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic efficacy of high-molecular-weight antigenic fractions of a recent clinical isolate of Leishmania donovani against visceral leishmaniasis.
    Tripathi P; Gupta SK; Sinha S; Sundar S; Dube A; Naik S
    Scand J Immunol; 2008 Nov; 68(5):492-501. PubMed ID: 18803606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal amyloidosis in hamsters with visceral leishmaniasis.
    González JL; Insa F; Novoa C; Pizarro M
    Br J Exp Pathol; 1986 Jun; 67(3):353-60. PubMed ID: 3718842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defects in the generation of IFN-gamma are overcome to control infection with Leishmania donovani in CC chemokine receptor (CCR) 5-, macrophage inflammatory protein-1 alpha-, or CCR2-deficient mice.
    Sato N; Kuziel WA; Melby PC; Reddick RL; Kostecki V; Zhao W; Maeda N; Ahuja SK; Ahuja SS
    J Immunol; 1999 Nov; 163(10):5519-25. PubMed ID: 10553079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
    Bhaumik SK; Naskar K; De T
    Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental infection with Leishmania in the dog: clinical, pathologic, parasitologic and serologic findings].
    Pospischil A; Fiebiger I; Krampitz HE; Weiland G
    Zentralbl Veterinarmed B; 1987 Jun; 34(4):288-304. PubMed ID: 3673364
    [No Abstract]   [Full Text] [Related]  

  • 12. Leishmania braziliensis in the squirrel monkey: development of primary and satellite lesions and lack of cross-immunity with Leishmania donovani.
    Lujan R; Chapman WL; Hanson WL; Dennis VA
    J Parasitol; 1990 Aug; 76(4):594-7. PubMed ID: 2380874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Observation on susceptibilities and immune responses of four strains of mice to the infection of a Leishmania donovani Chinese strain].
    Yi TL; Hu XS; Feng RY
    Sichuan Yi Xue Yuan Xue Bao; 1985 Jun; 16(2):122-6. PubMed ID: 3837361
    [No Abstract]   [Full Text] [Related]  

  • 14. Leishmania donovani: evolution and architecture of the splenic cellular immune response related to control of infection.
    Melby PC; Tabares A; Restrepo BI; Cardona AE; McGuff HS; Teale JM
    Exp Parasitol; 2001 Sep; 99(1):17-25. PubMed ID: 11708830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental visceral leishmaniasis in golden hamsters].
    Shukina EE; Gorbunova LA
    Parazitologiia; 1987; 21(5):637-42. PubMed ID: 3431905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental visceral leishmaniasis: role of endogenous IFN-gamma in host defense and tissue granulomatous response.
    Squires KE; Schreiber RD; McElrath MJ; Rubin BY; Anderson SL; Murray HW
    J Immunol; 1989 Dec; 143(12):4244-9. PubMed ID: 2512353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visceral spreading depletion of thymus-dependent regions and amyloidosis in mice and hamsters infected intradermally with Leishmania isolated from Sudanese cutaneous leishmaniasis.
    Veress B; Abdalla RE; El Hassan AM
    Br J Exp Pathol; 1983 Oct; 64(5):505-14. PubMed ID: 6605763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization of hamsters with TLCK-killed parasites induces protection against Leishmania infection.
    O'Daly JA; Cabrera Z
    Acta Trop; 1986 Sep; 43(3):225-36. PubMed ID: 2877549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral factors and nonspecific immune suppression in Syrian hamsters infected with Leishmania donovani.
    Evans TG; Smith D; Pearson RD
    J Parasitol; 1990 Apr; 76(2):212-7. PubMed ID: 2319422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of CXCR3 delays the development of hepatic inflammation but does not impair resistance to Leishmania donovani.
    Barbi J; Oghumu S; Rosas LE; Carlson T; Lu B; Gerard C; Lezama-Davila CM; Satoskar AR
    J Infect Dis; 2007 Jun; 195(11):1713-7. PubMed ID: 17471442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.